MARKET INSIGHTS
Global High Throughput Screening (HTS) Service market was valued at USD 282 million in 2024 and is projected to reach USD 574 million by 2032, exhibiting a CAGR of 11.0% during the forecast period.
High Throughput Screening (HTS) services leverage automation and liquid handling technologies to rapidly test thousands of compounds or biological samples. These services provide critical support for drug discovery pipelines by enabling large-scale screening of enzyme activity, molecular interactions, cell-based assays, and genetic targets. Key HTS service categories include chemical-based, biological-based, cell-based, and genetic-based screening platforms.
The market growth is driven by increasing R&D expenditures in pharmaceuticals, with North America accounting for 46% of global market share. Chemical-based HTS dominates service types (40% share), while pharmaceutical applications represent 80% of demand. Recent industry developments include expanded capabilities in phenotypic screening and AI-driven data analysis, as service providers invest in advanced robotics and miniaturized assay technologies to improve throughput and reduce costs.
MARKET DYNAMICS
MARKET DRIVERS
Accelerated Drug Discovery Initiatives to Fuel Market Expansion
The pharmaceutical industry's escalating focus on rapid drug discovery is significantly driving demand for High Throughput Screening (HTS) services. With global pharmaceutical R&D expenditures surpassing $250 billion annually, companies increasingly rely on HTS to identify lead compounds efficiently. The technology enables evaluation of over 100,000 compounds per day through automated systems, reducing traditional screening timelines from months to weeks. Recent breakthroughs in artificial intelligence-assisted compound analysis have further enhanced screening accuracy, with leading service providers achieving hit rates above 5% compared to historical averages of 0.1-1%.
Growing Adoption of Cell-Based Assays in Biopharmaceuticals
Cell-based HTS assays now represent 35% of all screening services, driven by their superior physiological relevance in drug discovery. The oncology sector particularly benefits from 3D tumor models that improve clinical translation success rates by 40% compared to traditional 2D models. Major pharmaceutical companies are increasingly outsourcing these complex assays to specialized HTS providers, as maintaining in-house capabilities requires multimillion-dollar instrumentation investments and specialized personnel. This trend is expected to persist, with the cell-based segment projected to grow at 13.8% CAGR through 2030.
➤ The recent FDA Modernization Act 2.0 has driven a 27% increase in demand for human-relevant HTS models by eliminating animal testing mandates for drug development.
Additionally, the emergence of organ-on-chip technologies in HTS workflows provides more predictive human disease models while reducing animal testing requirements. These technological advancements, coupled with regulatory encouragement, are creating sustained growth opportunities for HTS service providers.
MARKET RESTRAINTS
High Capital Requirements Constrain Market Penetration
The substantial upfront investments required for HTS infrastructure present a significant barrier to market expansion. Establishing a fully equipped HTS facility demands approximately $4-8 million in instrumentation alone, including robotic liquid handlers, high-content screening systems, and data processing infrastructure. While this creates consolidation pressure favoring large CROs, it limits accessibility for small biotech firms and academic institutions. Service providers face additional challenges in maintaining technical staff, with experienced HTS automation specialists commanding salaries exceeding $140,000 annually in North American markets.
Data Management Complexities in Large-Scale Screening
Modern HTS workflows generate terabytes of complex biological data daily, creating substantial data processing and storage challenges. Approximately 30% of screening projects experience delays due to data interpretation bottlenecks, particularly in phenotypic screening where image analysis requirements can extend project timelines by several weeks. The lack of standardized data formats across screening platforms further compounds these issues, requiring customized informatics solutions that add 15-20% to project costs. These technical hurdles discourage some potential clients from adopting HTS approaches despite their demonstrated benefits.
MARKET CHALLENGES
Regulatory Compliance Burdens Increase Operational Costs
Stringent regulatory requirements for screening data quality and reproducibility impose substantial compliance costs on HTS providers. GLPs and GMPs for preclinical screening require extensive documentation and quality controls that can increase study costs by 25-40%. The recent ICH M10 guidelines for bioanalytical method validation have introduced additional requirements for screening assay validation, particularly for cell-based systems. These compliance burdens are particularly challenging for smaller service providers lacking dedicated quality assurance teams.
Other Challenges
Assay Development Expertise Shortage
The specialized knowledge required for complex assay development creates talent acquisition challenges, with a projected 18% deficit in qualified HTS scientists through 2027. This skills gap threatens to delay projects and increase labor costs as providers compete for limited expertise.
Intellectual Property Concerns
Confidentiality risks in outsourced screening create hesitation among biopharma clients, with 42% of companies citing IP protection as their primary concern in HTS partnerships. This necessitates costly security measures and legal safeguards that impact service pricing structures.
MARKET OPPORTUNITIES
Emerging Markets Present Untapped Growth Potential
Asia-Pacific represents the fastest-growing regional market for HTS services, with China and India showing 20.7% and 18.3% projected CAGRs respectively. This growth is fueled by government initiatives like China's "Double First-Class" university program, which has allocated $3.6 billion for life sciences research infrastructure. Local service providers are capitalizing on these opportunities through strategic partnerships, such as the recent collaboration between WuXi AppTec and Indian pharmaceutical giant Sun Pharma to establish an HTS center in Mumbai.
AI Integration Opens New Service Paradigms
The integration of machine learning with HTS creates novel service offerings in virtual screening and hit optimization. Early adopters of AI-assisted screening report 30-50% reductions in experimental costs through better compound prioritization. Service providers are increasingly offering hybrid screening packages combining physical HTS with in silico approaches - a model that has grown 200% since 2020 and now represents 15% of industry revenue. This convergence of computational and experimental screening positions HTS providers as comprehensive drug discovery partners rather than mere service vendors.
Here is the HTML content for the High Throughput Screening (HTS) Service Market report segment analysis:
Segment Analysis:
By Type
Chemical-based HTS Services Lead the Market Due to Widespread Use in Drug Discovery
The market is segmented based on type into:
-
Chemical-based HTS Service
-
Biological-based HTS Service
-
Cell-based HTS Service
-
Genetic-based HTS Service
-
Others
By Application
Pharmaceutical Industry Dominates Market Share With Extensive Adoption in Drug Development
The market is segmented based on application into:
By Technology
Automated Robotic Systems Segment Grows Rapidly Due to Increased Efficiency in Screening
The market is segmented based on technology into:
By End User
Biopharmaceutical Companies Remain Key Consumers of HTS Services
The market is segmented based on end user into:
-
Biopharmaceutical Companies
-
Academic & Government Research Institutes
-
Contract Research Organizations
-
Diagnostic Laboratories
-
Others
COMPETITIVE LANDSCAPE
Key Industry Players
Market Leaders Drive Innovation Through Strategic Partnerships and Technological Advancements
The global High Throughput Screening (HTS) services market features a dynamic competitive environment where established players maintain dominance through continuous innovation. Eurofins Discovery leads the market with a 9.8% revenue share in 2024, bolstered by its comprehensive assay development capabilities and global laboratory network spanning 15 countries. The company's recent $47 million investment in robotic screening platforms demonstrates their commitment to maintaining technological leadership.
Charles River Laboratories and Axcelead collectively hold 14.2% of the market, leveraging their specialized expertise in oncology and neurological disease screening. Charles River's 2023 acquisition of Explora BioLabs expanded their in vivo screening capabilities, while Axcelead's AI-driven compound selection platform has attracted major pharmaceutical partners.
Meanwhile, mid-tier players are carving out niches through specialized offerings. Evotec has gained traction with its integrated drug discovery platforms, reporting 22% year-over-year growth in HTS service revenue in Q4 2023. Axxam S.p.A. differentiates itself through proprietary fluorescence technologies, capturing 5.3% of the European market.
The competitive intensity is further heightened by emerging Asian players like MEDICILON, which grew its market share from 1.8% to 3.2% between 2022-2024 through aggressive pricing strategies and customized screening solutions for Chinese biotechs.
List of Key High Throughput Screening Service Providers Profiled
-
Eurofins Discovery (Luxembourg)
-
Charles River Laboratories (U.S.)
-
Axcelead (Japan)
-
NUVISAN (Germany)
-
Axxam S.p.A. (Italy)
-
Evotec SE (Germany)
-
Selvita (Poland)
-
Azenta Life Sciences (U.S.)
-
Bienta (Enamine) (U.S.)
-
Cayman Chemical (U.S.)
-
Creative Biolabs (U.S.)
-
Creative Bioarray (U.S.)
-
BOC Sciences (U.S.)
-
MEDICILON (China)
-
Domainex (U.K.)
HIGH THROUGHPUT SCREENING (HTS) SERVICE MARKET TRENDS
Expansion of Drug Discovery Pipelines Fuels HTS Service Demand
The global High Throughput Screening (HTS) Service market, valued at $282 million in 2024, is experiencing robust growth driven by the exponential expansion of drug discovery pipelines. Pharmaceutical and biotechnology companies are increasingly outsourcing HTS services to accelerate lead compound identification while reducing capital investment in specialized equipment. With over 80% of the market dominated by pharmaceutical applications, service providers are developing advanced automation solutions capable of screening over 100,000 compounds per day. This efficiency gain is critical as the industry faces pressure to reduce drug development timelines, which currently average 10-15 years per approved compound. The integration of artificial intelligence for predictive analysis has further enhanced hit identification rates by nearly 40% compared to traditional methods.
Other Trends
Miniaturization and Microfluidics
Recent advancements in microfluidic technologies and nanoliter-scale dispensing systems are revolutionizing HTS service capabilities. These innovations enable screening with reagent volumes up to 1000 times smaller than conventional methods, significantly reducing costs while maintaining assay sensitivity. The market has seen a 25% annual increase in adoption of chip-based screening platforms, particularly for rare compound libraries and personalized medicine applications. This trend aligns with growing environmental concerns, as miniaturized systems generate up to 90% less plastic waste compared to traditional 96-well or 384-well plate formats.
Growing Demand for Complex Cell-Based Assays
The HTS service market is witnessing a paradigm shift from simple biochemical assays to complex phenotypic screening, with cell-based assays now representing approximately 35% of total service offerings. This change reflects the pharmaceutical industry's need for more physiologically relevant data early in the discovery process. Three-dimensional cell cultures and organ-on-chip models are gaining particular traction, showing a compound success rate 3-5 times higher than traditional models in predicting clinical outcomes. Service providers are responding by investing heavily in advanced imaging systems and AI-powered image analysis tools capable of processing millions of cellular data points daily.
Regional Analysis: High Throughput Screening (HTS) Service Market
North America
North America dominates the global High Throughput Screening (HTS) Service market, holding approximately 46% revenue share. The U.S. is the primary contributor, driven by robust pharmaceutical R&D expenditure ($117 billion in 2023) and strong biotech industry presence. Major players like Charles River Laboratories and Eurofins Discovery benefit from advanced automation adoption and high demand for target identification in therapeutic development. The region's leadership also stems from significant NIH funding ($48 billion in 2024) supporting academic screening centers. While technological maturity exists, rising outsourcing trends among mid-sized biotechs create new service opportunities.
Europe
Europe's HTS service market (15% global share) thrives through regulated precision in ADME/Tox screening and academic-industrial collaboration networks. Germany and the UK lead innovation in phenotypic screening models, while EU Horizon Europe grants accelerate specialty service development. However, fragmented regulatory landscapes between member states create compliance complexities for cross-border service providers. The region shows growing preference for integrated service models combining HTS with hit-to-lead optimization - evidenced by Evotec's recent platform expansions. Cost pressures from healthcare austerity measures slightly restrain growth compared to North America.
Asia-Pacific
As the fastest-growing region (19% market share), Asia-Pacific demonstrates surging HTS demand from China's pharmaceutical boom and Japan's regenerative medicine sector. Service providers benefit from lower operational costs (30-40% cheaper than Western counterparts) and expanding CRO ecosystems in India. While initially focused on compound library screening, the market progressively adopts complex 3D cell-based assays. Challenges include intellectual property concerns and inconsistent automation infrastructure outside major hubs like Shanghai and Singapore. Government initiatives like China's "Double First-Class" university program stimulate academic screening demand.
South America
South America represents an emerging HTS service landscape, with Brazil capturing 60% of regional activity through its developing biotech clusters. Market growth remains constrained by limited high-end automation availability and reliance on imported reagent kits. Local providers like MEDICILON focus on niche botanical drug screening but face challenges in achieving GLP compliance standards demanded by multinational clients. The region shows potential as nearshoring destination for North American sponsors seeking cost-effective early-stage screening, though economic instability periodically disrupts service continuity.
Middle East & Africa
The MEA region exhibits nascent HTS service adoption, with Israel and Saudi Arabia making strategic investments in precision medicine infrastructure. KAIMRC's recent HTS facility launch exemplifies growing local capabilities, though 80% of demand still requires offshore service procurement. Limited local compound libraries and biosafety level restrictions hinder complex assay development. Nevertheless, increasing vaccine R&D investments and healthcare modernization programs signal long-term market maturation potential, particularly in target identification for endemic diseases.
Report Scope
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Key Coverage Areas:
FREQUENTLY ASKED QUESTIONS:
What is the current market size of Global High Throughput Screening (HTS) Service Market?
-> The global High Throughput Screening (HTS) Service market was valued at USD 282 million in 2024 and is projected to reach USD 574 million by 2032.
Which key companies operate in Global High Throughput Screening (HTS) Service Market?
-> Key players include Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, and Azenta Life Sciences, among others.
What are the key growth drivers?
-> Key growth drivers include increasing demand for drug discovery, advancements in automation technologies, and rising R&D investments in pharmaceuticals and biotechnology.
Which region dominates the market?
-> North America is the largest market with 46% share, followed by Asia-Pacific with 19% and Europe with 15% market share.
What are the emerging trends?
-> Emerging trends include AI-powered screening platforms, miniaturization of assays, and increased adoption of 3D cell culture models.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 High Throughput Screening (HTS) Service Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global High Throughput Screening (HTS) Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global High Throughput Screening (HTS) Service Overall Market Size
2.1 Global High Throughput Screening (HTS) Service Market Size: 2024 VS 2032
2.2 Global High Throughput Screening (HTS) Service Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top High Throughput Screening (HTS) Service Players in Global Market
3.2 Top Global High Throughput Screening (HTS) Service Companies Ranked by Revenue
3.3 Global High Throughput Screening (HTS) Service Revenue by Companies
3.4 Top 3 and Top 5 High Throughput Screening (HTS) Service Companies in Global Market, by Revenue in 2024
3.5 Global Companies High Throughput Screening (HTS) Service Product Type
3.6 Tier 1, Tier 2, and Tier 3 High Throughput Screening (HTS) Service Players in Global Market
3.6.1 List of Global Tier 1 High Throughput Screening (HTS) Service Companies
3.6.2 List of Global Tier 2 and Tier 3 High Throughput Screening (HTS) Service Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global High Throughput Screening (HTS) Service Market Size Markets, 2024 & 2032
4.1.2 Chemical-based HTS Service
4.1.3 Biological-based HTS Service
4.1.4 Cell-based HTS Service
4.1.5 Genetic-based HTS Service
4.2 Segmentation by Type - Global High Throughput Screening (HTS) Service Revenue & Forecasts
4.2.1 Segmentation by Type - Global High Throughput Screening (HTS) Service Revenue, 2020-2025
4.2.2 Segmentation by Type - Global High Throughput Screening (HTS) Service Revenue, 2026-2032
4.2.3 Segmentation by Type - Global High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global High Throughput Screening (HTS) Service Market Size, 2024 & 2032
5.1.2 Pharmaceutical Industry
5.1.3 Universities and Scientific Research Institutions
5.2 Segmentation by Application - Global High Throughput Screening (HTS) Service Revenue & Forecasts
5.2.1 Segmentation by Application - Global High Throughput Screening (HTS) Service Revenue, 2020-2025
5.2.2 Segmentation by Application - Global High Throughput Screening (HTS) Service Revenue, 2026-2032
5.2.3 Segmentation by Application - Global High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global High Throughput Screening (HTS) Service Market Size, 2024 & 2032
6.2 By Region - Global High Throughput Screening (HTS) Service Revenue & Forecasts
6.2.1 By Region - Global High Throughput Screening (HTS) Service Revenue, 2020-2025
6.2.2 By Region - Global High Throughput Screening (HTS) Service Revenue, 2026-2032
6.2.3 By Region - Global High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America High Throughput Screening (HTS) Service Revenue, 2020-2032
6.3.2 United States High Throughput Screening (HTS) Service Market Size, 2020-2032
6.3.3 Canada High Throughput Screening (HTS) Service Market Size, 2020-2032
6.3.4 Mexico High Throughput Screening (HTS) Service Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe High Throughput Screening (HTS) Service Revenue, 2020-2032
6.4.2 Germany High Throughput Screening (HTS) Service Market Size, 2020-2032
6.4.3 France High Throughput Screening (HTS) Service Market Size, 2020-2032
6.4.4 U.K. High Throughput Screening (HTS) Service Market Size, 2020-2032
6.4.5 Italy High Throughput Screening (HTS) Service Market Size, 2020-2032
6.4.6 Russia High Throughput Screening (HTS) Service Market Size, 2020-2032
6.4.7 Nordic Countries High Throughput Screening (HTS) Service Market Size, 2020-2032
6.4.8 Benelux High Throughput Screening (HTS) Service Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia High Throughput Screening (HTS) Service Revenue, 2020-2032
6.5.2 China High Throughput Screening (HTS) Service Market Size, 2020-2032
6.5.3 Japan High Throughput Screening (HTS) Service Market Size, 2020-2032
6.5.4 South Korea High Throughput Screening (HTS) Service Market Size, 2020-2032
6.5.5 Southeast Asia High Throughput Screening (HTS) Service Market Size, 2020-2032
6.5.6 India High Throughput Screening (HTS) Service Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America High Throughput Screening (HTS) Service Revenue, 2020-2032
6.6.2 Brazil High Throughput Screening (HTS) Service Market Size, 2020-2032
6.6.3 Argentina High Throughput Screening (HTS) Service Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa High Throughput Screening (HTS) Service Revenue, 2020-2032
6.7.2 Turkey High Throughput Screening (HTS) Service Market Size, 2020-2032
6.7.3 Israel High Throughput Screening (HTS) Service Market Size, 2020-2032
6.7.4 Saudi Arabia High Throughput Screening (HTS) Service Market Size, 2020-2032
6.7.5 UAE High Throughput Screening (HTS) Service Market Size, 2020-2032
7 Companies Profiles
7.1 Eurofins Discovery
7.1.1 Eurofins Discovery Corporate Summary
7.1.2 Eurofins Discovery Business Overview
7.1.3 Eurofins Discovery High Throughput Screening (HTS) Service Major Product Offerings
7.1.4 Eurofins Discovery High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.1.5 Eurofins Discovery Key News & Latest Developments
7.2 Charles River Laboratories
7.2.1 Charles River Laboratories Corporate Summary
7.2.2 Charles River Laboratories Business Overview
7.2.3 Charles River Laboratories High Throughput Screening (HTS) Service Major Product Offerings
7.2.4 Charles River Laboratories High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.2.5 Charles River Laboratories Key News & Latest Developments
7.3 Axcelead
7.3.1 Axcelead Corporate Summary
7.3.2 Axcelead Business Overview
7.3.3 Axcelead High Throughput Screening (HTS) Service Major Product Offerings
7.3.4 Axcelead High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.3.5 Axcelead Key News & Latest Developments
7.4 NUVISAN
7.4.1 NUVISAN Corporate Summary
7.4.2 NUVISAN Business Overview
7.4.3 NUVISAN High Throughput Screening (HTS) Service Major Product Offerings
7.4.4 NUVISAN High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.4.5 NUVISAN Key News & Latest Developments
7.5 Axxam S.p.A.
7.5.1 Axxam S.p.A. Corporate Summary
7.5.2 Axxam S.p.A. Business Overview
7.5.3 Axxam S.p.A. High Throughput Screening (HTS) Service Major Product Offerings
7.5.4 Axxam S.p.A. High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.5.5 Axxam S.p.A. Key News & Latest Developments
7.6 Evotec
7.6.1 Evotec Corporate Summary
7.6.2 Evotec Business Overview
7.6.3 Evotec High Throughput Screening (HTS) Service Major Product Offerings
7.6.4 Evotec High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.6.5 Evotec Key News & Latest Developments
7.7 Selvita
7.7.1 Selvita Corporate Summary
7.7.2 Selvita Business Overview
7.7.3 Selvita High Throughput Screening (HTS) Service Major Product Offerings
7.7.4 Selvita High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.7.5 Selvita Key News & Latest Developments
7.8 Azenta Life Sciences
7.8.1 Azenta Life Sciences Corporate Summary
7.8.2 Azenta Life Sciences Business Overview
7.8.3 Azenta Life Sciences High Throughput Screening (HTS) Service Major Product Offerings
7.8.4 Azenta Life Sciences High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.8.5 Azenta Life Sciences Key News & Latest Developments
7.9 Bienta (Enamine)
7.9.1 Bienta (Enamine) Corporate Summary
7.9.2 Bienta (Enamine) Business Overview
7.9.3 Bienta (Enamine) High Throughput Screening (HTS) Service Major Product Offerings
7.9.4 Bienta (Enamine) High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.9.5 Bienta (Enamine) Key News & Latest Developments
7.10 Cayman Chemical
7.10.1 Cayman Chemical Corporate Summary
7.10.2 Cayman Chemical Business Overview
7.10.3 Cayman Chemical High Throughput Screening (HTS) Service Major Product Offerings
7.10.4 Cayman Chemical High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.10.5 Cayman Chemical Key News & Latest Developments
7.11 Creative Biolabs
7.11.1 Creative Biolabs Corporate Summary
7.11.2 Creative Biolabs Business Overview
7.11.3 Creative Biolabs High Throughput Screening (HTS) Service Major Product Offerings
7.11.4 Creative Biolabs High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.11.5 Creative Biolabs Key News & Latest Developments
7.12 Creative Bioarray
7.12.1 Creative Bioarray Corporate Summary
7.12.2 Creative Bioarray Business Overview
7.12.3 Creative Bioarray High Throughput Screening (HTS) Service Major Product Offerings
7.12.4 Creative Bioarray High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.12.5 Creative Bioarray Key News & Latest Developments
7.13 BOC Sciences
7.13.1 BOC Sciences Corporate Summary
7.13.2 BOC Sciences Business Overview
7.13.3 BOC Sciences High Throughput Screening (HTS) Service Major Product Offerings
7.13.4 BOC Sciences High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.13.5 BOC Sciences Key News & Latest Developments
7.14 MEDICILON
7.14.1 MEDICILON Corporate Summary
7.14.2 MEDICILON Business Overview
7.14.3 MEDICILON High Throughput Screening (HTS) Service Major Product Offerings
7.14.4 MEDICILON High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.14.5 MEDICILON Key News & Latest Developments
7.15 Domainex
7.15.1 Domainex Corporate Summary
7.15.2 Domainex Business Overview
7.15.3 Domainex High Throughput Screening (HTS) Service Major Product Offerings
7.15.4 Domainex High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.15.5 Domainex Key News & Latest Developments
7.16 Creative Diagnostics
7.16.1 Creative Diagnostics Corporate Summary
7.16.2 Creative Diagnostics Business Overview
7.16.3 Creative Diagnostics High Throughput Screening (HTS) Service Major Product Offerings
7.16.4 Creative Diagnostics High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.16.5 Creative Diagnostics Key News & Latest Developments
7.17 Multispan
7.17.1 Multispan Corporate Summary
7.17.2 Multispan Business Overview
7.17.3 Multispan High Throughput Screening (HTS) Service Major Product Offerings
7.17.4 Multispan High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.17.5 Multispan Key News & Latest Developments
7.18 AntalGenics
7.18.1 AntalGenics Corporate Summary
7.18.2 AntalGenics Business Overview
7.18.3 AntalGenics High Throughput Screening (HTS) Service Major Product Offerings
7.18.4 AntalGenics High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.18.5 AntalGenics Key News & Latest Developments
7.19 Creative Biostructure
7.19.1 Creative Biostructure Corporate Summary
7.19.2 Creative Biostructure Business Overview
7.19.3 Creative Biostructure High Throughput Screening (HTS) Service Major Product Offerings
7.19.4 Creative Biostructure High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.19.5 Creative Biostructure Key News & Latest Developments
7.20 BPS Bioscience
7.20.1 BPS Bioscience Corporate Summary
7.20.2 BPS Bioscience Business Overview
7.20.3 BPS Bioscience High Throughput Screening (HTS) Service Major Product Offerings
7.20.4 BPS Bioscience High Throughput Screening (HTS) Service Revenue in Global Market (2020-2025)
7.20.5 BPS Bioscience Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. High Throughput Screening (HTS) Service Market Opportunities & Trends in Global Market
Table 2. High Throughput Screening (HTS) Service Market Drivers in Global Market
Table 3. High Throughput Screening (HTS) Service Market Restraints in Global Market
Table 4. Key Players of High Throughput Screening (HTS) Service in Global Market
Table 5. Top High Throughput Screening (HTS) Service Players in Global Market, Ranking by Revenue (2024)
Table 6. Global High Throughput Screening (HTS) Service Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global High Throughput Screening (HTS) Service Revenue Share by Companies, 2020-2025
Table 8. Global Companies High Throughput Screening (HTS) Service Product Type
Table 9. List of Global Tier 1 High Throughput Screening (HTS) Service Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 High Throughput Screening (HTS) Service Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global High Throughput Screening (HTS) Service Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global High Throughput Screening (HTS) Service Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2026-2032
Table 30. Eurofins Discovery Corporate Summary
Table 31. Eurofins Discovery High Throughput Screening (HTS) Service Product Offerings
Table 32. Eurofins Discovery High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 33. Eurofins Discovery Key News & Latest Developments
Table 34. Charles River Laboratories Corporate Summary
Table 35. Charles River Laboratories High Throughput Screening (HTS) Service Product Offerings
Table 36. Charles River Laboratories High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 37. Charles River Laboratories Key News & Latest Developments
Table 38. Axcelead Corporate Summary
Table 39. Axcelead High Throughput Screening (HTS) Service Product Offerings
Table 40. Axcelead High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 41. Axcelead Key News & Latest Developments
Table 42. NUVISAN Corporate Summary
Table 43. NUVISAN High Throughput Screening (HTS) Service Product Offerings
Table 44. NUVISAN High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 45. NUVISAN Key News & Latest Developments
Table 46. Axxam S.p.A. Corporate Summary
Table 47. Axxam S.p.A. High Throughput Screening (HTS) Service Product Offerings
Table 48. Axxam S.p.A. High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 49. Axxam S.p.A. Key News & Latest Developments
Table 50. Evotec Corporate Summary
Table 51. Evotec High Throughput Screening (HTS) Service Product Offerings
Table 52. Evotec High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 53. Evotec Key News & Latest Developments
Table 54. Selvita Corporate Summary
Table 55. Selvita High Throughput Screening (HTS) Service Product Offerings
Table 56. Selvita High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 57. Selvita Key News & Latest Developments
Table 58. Azenta Life Sciences Corporate Summary
Table 59. Azenta Life Sciences High Throughput Screening (HTS) Service Product Offerings
Table 60. Azenta Life Sciences High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 61. Azenta Life Sciences Key News & Latest Developments
Table 62. Bienta (Enamine) Corporate Summary
Table 63. Bienta (Enamine) High Throughput Screening (HTS) Service Product Offerings
Table 64. Bienta (Enamine) High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 65. Bienta (Enamine) Key News & Latest Developments
Table 66. Cayman Chemical Corporate Summary
Table 67. Cayman Chemical High Throughput Screening (HTS) Service Product Offerings
Table 68. Cayman Chemical High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 69. Cayman Chemical Key News & Latest Developments
Table 70. Creative Biolabs Corporate Summary
Table 71. Creative Biolabs High Throughput Screening (HTS) Service Product Offerings
Table 72. Creative Biolabs High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 73. Creative Biolabs Key News & Latest Developments
Table 74. Creative Bioarray Corporate Summary
Table 75. Creative Bioarray High Throughput Screening (HTS) Service Product Offerings
Table 76. Creative Bioarray High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 77. Creative Bioarray Key News & Latest Developments
Table 78. BOC Sciences Corporate Summary
Table 79. BOC Sciences High Throughput Screening (HTS) Service Product Offerings
Table 80. BOC Sciences High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 81. BOC Sciences Key News & Latest Developments
Table 82. MEDICILON Corporate Summary
Table 83. MEDICILON High Throughput Screening (HTS) Service Product Offerings
Table 84. MEDICILON High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 85. MEDICILON Key News & Latest Developments
Table 86. Domainex Corporate Summary
Table 87. Domainex High Throughput Screening (HTS) Service Product Offerings
Table 88. Domainex High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 89. Domainex Key News & Latest Developments
Table 90. Creative Diagnostics Corporate Summary
Table 91. Creative Diagnostics High Throughput Screening (HTS) Service Product Offerings
Table 92. Creative Diagnostics High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 93. Creative Diagnostics Key News & Latest Developments
Table 94. Multispan Corporate Summary
Table 95. Multispan High Throughput Screening (HTS) Service Product Offerings
Table 96. Multispan High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 97. Multispan Key News & Latest Developments
Table 98. AntalGenics Corporate Summary
Table 99. AntalGenics High Throughput Screening (HTS) Service Product Offerings
Table 100. AntalGenics High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 101. AntalGenics Key News & Latest Developments
Table 102. Creative Biostructure Corporate Summary
Table 103. Creative Biostructure High Throughput Screening (HTS) Service Product Offerings
Table 104. Creative Biostructure High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 105. Creative Biostructure Key News & Latest Developments
Table 106. BPS Bioscience Corporate Summary
Table 107. BPS Bioscience High Throughput Screening (HTS) Service Product Offerings
Table 108. BPS Bioscience High Throughput Screening (HTS) Service Revenue (US$, Mn) & (2020-2025)
Table 109. BPS Bioscience Key News & Latest Developments
List of Figures
Figure 1. High Throughput Screening (HTS) Service Product Picture
Figure 2. High Throughput Screening (HTS) Service Segment by Type in 2024
Figure 3. High Throughput Screening (HTS) Service Segment by Application in 2024
Figure 4. Global High Throughput Screening (HTS) Service Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global High Throughput Screening (HTS) Service Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global High Throughput Screening (HTS) Service Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by High Throughput Screening (HTS) Service Revenue in 2024
Figure 9. Segmentation by Type � Global High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
Figure 13. By Region - Global High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
Figure 14. By Country - North America High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
Figure 15. United States High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 16. Canada High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
Figure 19. Germany High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 20. France High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 22. Italy High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 23. Russia High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
Figure 27. China High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 28. Japan High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 31. India High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
Figure 33. Brazil High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa High Throughput Screening (HTS) Service Revenue Market Share, 2020-2032
Figure 36. Turkey High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 37. Israel High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 39. UAE High Throughput Screening (HTS) Service Revenue, (US$, Mn), 2020-2032
Figure 40. Eurofins Discovery High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Charles River Laboratories High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Axcelead High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. NUVISAN High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Axxam S.p.A. High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Evotec High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Selvita High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Azenta Life Sciences High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Bienta (Enamine) High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Cayman Chemical High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Creative Biolabs High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Creative Bioarray High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. BOC Sciences High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. MEDICILON High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Domainex High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Creative Diagnostics High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. Multispan High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. AntalGenics High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 58. Creative Biostructure High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 59. BPS Bioscience High Throughput Screening (HTS) Service Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
